1 Department of Gastroenterology, Abdominal Centre, Rigshospitalet, The Capital Region of Denmark2 Medical Scientific Strategy, Takeda GmbH, Byk-Gulden-Str. 2, 78467 Konstanz, Germany. Electronic address: firstname.lastname@example.org unknown
Subjects with short bowel syndrome (SBS) have impaired quality of life (QoL). No disease-specific instrument has been available to measure treatment-induced changes in QoL over time. Therefore, the aim was to develop and validate an SBS-specific QoL scale.